KGI's MBS program is structured over two years, integrating graduate-level courses in both science and bioscience management. The focuses on core bioscience business courses (strategy, corporate finance, industry dynamics, data analytics) and translational science courses (drug discovery and development, bioprocessing, medical devices, medical diagnostics). The summer between the first and second year includes a required industry internship, providing real-world experience.
Curriculum: The MBS curriculum is highly interdisciplinary, combining rigorous scientific knowledge with essential business principles. Core coursework covers areas such as bioscience business strategy, corporate finance, bioscience industry dynamics, and data analytics. On the scientific side, students delve into translational science topics like drug discovery and development, bioprocessing, medical devices, and medical diagnostics. A critical component is the professional development coursework, including skills workshops and industry talks. In their second year, students can choose from career-oriented concentrations such as Biotech Management, Operations and Supply Chain Management, Regulatory Affairs, or Data Analytics, allowing for focused studies that align with specific industry career paths.
Research Focus: KGI's MBS program has a distinctive applied research and project-based focus rather than traditional academic research. The hallmark of this practical approach is the Team Master's Project (TMP). In this year-long capstone, teams of three to five students work directly with sponsoring biotech, pharmaceutical, and healthcare companies on real-world consulting assignments. These projects encompass both business and technical aspects, requiring students to develop budgets, timelines, and deliver tangible solutions. This experiential learning provides unparalleled real-world practice, translating scientific knowledge and business strategies into actionable results. The program's overall ethos is about translating scientific breakthroughs into market-ready products and solutions.
Industry Engagement: Industry engagement is a cornerstone of the KGI MBS program. The Institute was established in response to the life science industry's need for professionals who could effectively combine science and business. This commitment is evident through several avenues: faculty members often have extensive industry backgrounds, bringing real-world insights into the classroom; required summer internships provide direct experience in bioscience companies; and the year-long Team Master's Project involves direct collaboration with sponsoring companies. KGI also maintains strong, collaborative ties with leading life science companies—from innovative startups to established pharmaceutical giants—through its Industry Advisory Boards and regular industry talks, ensuring graduates are well-networked and "ready now" for the demands of the sector.
Global Perspective: While the KGI MBS program doesn't specifically highlight dedicated "global business" courses in its core curriculum, its inherent nature, preparing graduates for the bioscience industries, naturally encompasses a global perspective. Biotechnology, pharmaceuticals, and healthcare are inherently global industries, with research, development, manufacturing, and distribution often spanning multiple countries. The program's focus on industry dynamics, regulatory affairs, and supply chain management, particularly within the context of large multinational biopharma companies, implicitly addresses global challenges and opportunities. KGI's mission to "enrich society with breakthrough approaches in education and translational research in healthcare and the life sciences" and its emphasis on developing leaders for the global bioscience community further suggest an ingrained global outlook, preparing students to contribute to an internationally interconnected industry.